Skip to main content
    O

    Organon & Co (OGN)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $13.91
    +0.01 (+0.07%)

    Market Cap: $3.65B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Organon & Co (OGN) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Organon (OGN) trades at 4.6x trailing earnings and 0.6x sales. Its P/E of 4.6x is above its 5-year median of 4.3x. Its forward P/E is 5.1x. The median P/E across 8 similar companies is 27.3x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 9.8% lower over the next year. Its free cash flow yield is 18.5%.

    MultipleValue
    P/E (trailing)4.6x
    Forward P/E5.1x
    Price to sales0.6x
    Price to book3.1x
    EV/EBITDA8.4x
    Price to FCF5.4x
    EV/FCF15.9x
    PEGN/A
    FCF yield18.5%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/E4.6x4.3xN/A
    P/S0.6x0.7xN/A
    Medians of month-end values through Oct 2026: 59 to 60 months (5-year).

    Valuation History

    Over the 5 year ends shown, its P/E ranged from 2.0x in 2025 to 5.6x in 2022. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$7.172.0x0.3x2.5x
    2024$14.923.6x0.6x8.2x
    2023$14.423.5x0.6xN/A
    2022$27.935.6x1.2xN/A
    2021$30.454.8x1.2xN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OGN

    What is OGN's forward P/E ratio?

    Organon has a forward P/E ratio of 5.1x.

    Is OGN stock overvalued?

    GNG's valuation label for OGN is Undervalued. Its P/E of 4.6x compares with a median of 27.3x across 8 similar companies.

    What is OGN's price to sales ratio?

    Organon has a price to sales ratio of 0.6x.

    What is Organon's average P/E ratio over 5 years?

    Organon's median P/E over the last 5 years is 4.3x, from 59 month-end values through Oct 2026.